What the company does
Biomm S.A. operates as a biotechnology company in Brazil. The company offers insulin products for the treatment of diabetes, including AFREZZA, a human insulin powder for inhalation; GLARGILIN, a glargine insulin; WOSULIN N and WOSULIN R; Lifepen G, a reusable insulin injection pen; and Biopemm, a reusable insulin delivery device for diabetic patients. It also provides Bevyx for the treatment of metastatic colorectal cancer; HERZUMA for the treatment of early-stage and metastatic breast cancer and metastatic gastric cancer with HER2-positive tumors; GHEMAXAN, an anticoagulant for the treatment of deep vein thrombosis and pulmonary embolism, unstable …
What the weekly tape is saying
BIOM3 closed the latest completed week at 6.70 BRL. The 4-week return is -10.1% and the 12-week return is -7.6%. Trend Signal is inactive, Market Dynamics is 0.03. Setup signature: Risk-first tape with a 13/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 7.15 BRL
- Vs Trend Line
- -6.3%
- Fair Value
- 8.44 BRL
- Vs Fair Value
- -20.6%
- 52W High
- 10.39 BRL
- 52W Low
- 5.75 BRL
- Drawdown
- -35.5%
- Range Position
- 20.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 1
- 52W Active Breadth
- 1.9%
- Sector Scope
- BR Healthcare
- Sector Rank
- 67 of 80
- Sector Percentile
- 16.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
BR Healthcare
- Tracked Peers
- 80
- 4W Rank
- 70 of 80
- Avg 1W
- 1.2%
- Avg 4W
- 3.5%
- Trend Breadth
- 20.0%
- Positive MD
- 31.3%
BR Biotechnology
- Tracked Peers
- 12
- 4W Rank
- 9 of 12
- Avg 1W
- 1.3%
- Avg 4W
- 1.2%
- Trend Breadth
- 8.3%
- Positive RS
- 25.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.03
- 4W MD Change
- -96.5%
- Relative Strength
- -17.35
- 4W RS Change
- -16.9%
- Expectation
- Undecided
- Probability
- 47.08%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 429.0K
- 13W Average
- 3.9M
- 52W Average
- 1.2M
- Vs 13W
- 0.1x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.0%
- 52W Volatility
- 8.6%
- Upside Weeks
- 23
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 6.4% / -4.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- SAO
- Country
- BR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- BRL
- Market Cap
- 952.5M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- Latest weekly return ranks in the weaker part of its sector group.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 6.70 BRL | -2.0% | 7.15 BRL | 8.44 BRL | 0.03 | -17.35 | 429.0K | Off |
| 5 Jun 2026 | 6.84 BRL | -4.1% | 7.17 BRL | 8.43 BRL | 0.38 | -14.98 | 229.6K | Off |
| 29 May 2026 | 7.13 BRL | -1.7% | 7.17 BRL | 8.42 BRL | 0.62 | -14.65 | 2.4M | Off |
| 22 May 2026 | 7.25 BRL | -2.7% | 7.19 BRL | 8.41 BRL | 0.83 | -15.50 | 1.8M | Off |
| 15 May 2026 | 7.45 BRL | -0.1% | 7.25 BRL | 8.40 BRL | 0.79 | -14.85 | 682.2K | Off |
| 8 May 2026 | 7.46 BRL | -0.5% | 7.34 BRL | 8.39 BRL | 0.75 | -18.88 | 310.5K | Off |
| 1 May 2026 | 7.50 BRL | 1.5% | 7.43 BRL | 8.36 BRL | 0.72 | -20.84 | 42.3M | Off |
| 24 Apr 2026 | 7.39 BRL | -3.1% | 7.52 BRL | 8.34 BRL | 0.74 | -24.42 | 146.3K | Off |
| 17 Apr 2026 | 7.63 BRL | 3.8% | 7.60 BRL | 8.31 BRL | 0.78 | -24.99 | 231.1K | Off |
| 10 Apr 2026 | 7.35 BRL | -3.9% | 7.63 BRL | 8.29 BRL | 0.64 | -29.27 | 386.8K | Off |
| 3 Apr 2026 | 7.65 BRL | 4.8% | 7.66 BRL | 8.27 BRL | 0.32 | -23.80 | 708.5K | Off |
| 27 Mar 2026 | 7.30 BRL | 0.7% | 7.64 BRL | 8.24 BRL | 0.02 | -25.59 | 285.8K | Off |
| 20 Mar 2026 | 7.25 BRL | 4.3% | 7.62 BRL | 8.22 BRL | -0.33 | -24.75 | 313.3K | Off |
| 13 Mar 2026 | 6.95 BRL | -6.1% | 7.61 BRL | 8.20 BRL | -0.63 | -29.32 | 241.2K | Off |